Clinical Trials on Relapsed or Refractory Multiple Myeloma
Total 8488 results
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
MiNK TherapeuticsCompletedRelapsed/Refractory Multiple MyelomaUnited States
-
AbbVieActive, not recruiting
-
Sun Yat-sen UniversityUnknownRelapsed, Refractory, Multiple MyelomaChina
-
Nanjing Leads Biolabs Co.,LtdRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Chunrui LiInnovent Biologics (Suzhou) Co. Ltd.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Allarity TherapeuticsMedical Prognosis Institute A/S; Smerud Medical Research International ASTerminatedRelapsed/Refractory Multiple MyelomaDenmark
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
Epizyme, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B Cell Lymphoma Refractory | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
Memorial Sloan Kettering Cancer CenterRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Relapsed Acute Myeloid LeukemiaUnited States
-
The Cleveland ClinicWithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Immunovative Therapies, Ltd.TerminatedAdvanced or Refractory Leukemia, Lymphoma, Multiple MyelomaUnited States
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.Not yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Weijun FuNanjing Legend Biotech Co.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
The First Affiliated Hospital of Soochow UniversityWithdrawnRelapsed/Refractory Multiple MyelomaChina
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Sara V. LatorreInstituto de Salud Carlos III; Fondos ARI (Assistencia Recerca Intensiva); Fondo...Active, not recruiting
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
The First Affiliated Hospital of Soochow UniversityInnovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Multiple MyelomaChina
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
AmgenWithdrawnRelapsed/Refractory Multiple Myeloma
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Weijun FuNanjing Legend Biotech Co.Active, not recruiting